Internal Medicine, Hematology & Oncology · Orlando, FL
NPI
1265417505
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
22 W Underwood St
Orlando, FL, 32806
Phone (407) 648-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
685 services
Medicare patients, 2024
299
Average age 74
Drug cost, 2024
$3.1M
1,767 prescriptions
Company payments, 2025
$64K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nikita C Shah was code 99214 (office e&m - established), 274 times for 170 patients. In total Nikita C Shah billed 685 services in 16 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 274 | 170 | $61.21 | $17K |
| 99215 Office E&M - Established | Facility | 141 | 65 | $107.58 | $15K |
| 99213 Office E&M - Established | Facility | 63 | 49 | $44.39 | $2,797 |
| 99205 Office E&M - New | Facility | 43 | 43 | $139.42 | $5,995 |
| 99214 Office E&M - Established | Office | 41 | 40 | $95.83 | $3,929 |
| 99233 Hospital E&M - Subsequent | Facility | 28 | 15 | $92.58 | $2,592 |
| 99223 Hospital E&M - Initial | Facility | 23 | 22 | $135.14 | $3,108 |
| 99222 Hospital E&M - Initial | Facility | 21 | 20 | $102.41 | $2,151 |
| 99215 Office E&M - Established | Office | 19 | 14 | $115.98 | $2,204 |
| 99213 Office E&M - Established | Office | 15 | 14 | $61.85 | $928 |
By year: 2022 $55K for 772 services; 2023 $52K for 725 services; 2024 $57K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nikita C Shah prescribed most often to Medicare patients was Anastrozole, with 698 prescriptions and refills. In total Nikita C Shah wrote 1,767 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 698 | 2,045 | 232 | $13K |
| Letrozole Generic | 210 | 578 | 69 | $5,323 |
| Kisqali Ribociclib Succinate | 89 | 89 | 12 | $1.3M |
| Prochlorperazine Maleate Generic | 77 | 77 | 52 | $1,202 |
| Ibrance Palbociclib | 67 | 67 | Under 11 | $982K |
| Ondansetron Hcl Generic | 60 | 61 | 45 | $1,862 |
| Tamoxifen Citrate Generic | 47 | 132 | 15 | $993 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 41 | 44 | 31 | $529 |
| Pantoprazole Sodium Generic | 41 | 95 | 27 | $345 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 34 | 50 | Under 11 | $282 |
| Lorazepam Generic | 33 | 33 | 20 | $150 |
| Gabapentin Generic | 29 | 65 | Under 11 | $539 |
| Exemestane Generic | 29 | 61 | Under 11 | $5,897 |
| Olanzapine Generic | 28 | 32 | 18 | $232 |
| Eliquis Apixaban | 26 | 28 | Under 11 | $15K |
Brand drugs: 253 claims; generic drugs: 1,514 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nikita C Shah $64K ($64K in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $31K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 28 | $31K |
| Daiichi Sankyo Inc. 4568.T | 20 | $24K |
| Novartis Pharmaceuticals Corporation NVS | 17 | $7,050 |
| Lantheus Medical Imaging, Inc. LNTH | 1 | $428 |
| Leica Microsystems Inc. | 1 | $285 |
| Puma Biotechnology, Inc. PBYI | 1 | $120 |
| Dompe US, Inc. | 1 | $119 |
| GlaxoSmithKline, LLC. GSK | 3 | $41.63 |
| Stryker Corporation SYK | 1 | $30.59 |
| Merck Sharp & Dohme LLC MRK | 1 | $25.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.